Articles tagged with Cell Apoptosis
A new study reveals a connection between necroptosis, a type of programmed cell death, and inflammatory diseases such as Crohn's disease, rheumatoid arthritis, and psoriasis. RIPK1 is identified as the molecule that regulates this process, allowing cells to choose whether to live or die.
Researchers at McGill University found that free radicals stimulate a molecular mechanism that increases cell defenses and promotes longevity. The study used the roundworm C. elegans as a model organism and found that elevating free radical generation induced a substantially longer life.
A study published in Cell Death & Disease found that an overabundance of c-FLIPR protein disrupts the immune system's balance. Researchers discovered that this imbalance leads to autoantibodies attacking the body's own tissues, resulting in autoimmune diseases like systemic lupus erythematosus.
Researchers at Virginia Commonwealth University identified how zinc interacts with caspase-3 to regulate apoptosis. The findings may lead to targeted drug interventions for treating cancer and neurodegenerative diseases.
Scientists have discovered a molecule that can induce cell death (apoptosis) in dendritic cells, a key type of immune cell. This understanding may lead to new therapies that shut down dendritic cell activity and reduce an immune reaction.
Scientists discover that when one cell dies due to DNA damage, its neighbors are alerted and become harder to kill. This finding challenges previous views on apoptosis and could have implications for cancer therapy.
Pretreatment with SSTF reduces infarct volume and apoptosis in hippocampal neurons, restoring neurological deficits and improving the integrity of the blood-brain barrier. SSTF increases Bcl-2 expression and decreases Bax expression, suggesting multiple pathways for neuroprotection.
Researchers at Brigham Young University have discovered a potential target for tumor suppression, Programmed Cell Death Protein 5 (PDCD5), which may help prevent cancer cell growth by blocking the production of tubulin. The study provides new insights into how PDCD5 functions and offers a promising direction for future research.
The ClC-3 chloride channel is involved in the regulation of neuronal survival and apoptosis. Nitric oxide overproduction induces ClC-3 expression, promoting apoptosis. DIDS reverses this effect, suggesting a correlation between ClC-3 activity and ischemia-sensitive apoptosis.
Researchers found that pre-moxibustion prior to Aβ1–42 exposure was more effective than moxibustion after Aβ1–42 exposure in protecting neuronal structure and lowering apoptosis rate. Moxibustion therapy may have a beneficial effect on preventing Alzheimer's disease development.
A study by Jiang et al. found that baicalin inhibited colistin sulfate-induced neuronal apoptosis in PC12 cells by suppressing free radical injury, reducing caspase-3 activity and lactate dehydrogenase activity. Cell viability increased, and cell morphology improved.
Researchers at the University of Colorado have synthesized the most active component of grape seed extract, B2G2, which induces apoptosis in prostate cancer cells while leaving healthy cells unharmed. The findings suggest that B2G2 is a promising lead compound for future clinical trials and preclinical studies.
Researchers found TLR4 signaling increases apoptotic ratio in hippocampal neurons stimulated by lipopolysaccharide. Inhibiting AKT and GSK-3β pathways decreases active Caspase-3 and Bax/Bcl-2 ratios, suggesting a new target for neurodegenerative disease treatment.
A team of researchers discovered that abnormal mitochondria may be responsible for cancer cells' resistance to radiation therapy. The study found that a mutation in the E2F gene led to dysfunctional mitochondria that produced less energy, making cancer cells more resistant to radiation-induced cell death.
Researchers have found that oligomeric proanthocyanidin has a protective effect on retinal ganglion cells against oxidative stress-induced injury, providing potential treatment for neural diseases. The compound, enriched in grape seeds, shows promise in preventing cell death in optic neurodegenerative conditions.
A recent study published in Neural Regeneration Research found that propofol can inhibit damage caused by proinflammatory cytokines and exert protective effects on the central nervous system. The experimental findings indicate that propofol promotes regeneration following sciatic nerve injury by reducing inflammation and apoptosis.
Scientists found that BMAA inserts itself into neuroproteins by seizing transfer RNA, causing misfolding and aggregation. Adding extra L-Serine can prevent this process, offering a potential prevention method for ALS.
Researchers found a molecular mechanism linking mechanical ventilation to hippocampal damage and mental impairment in ICU patients. The study suggests that elevated dopamine levels may contribute to the development of neurobehavioral disorders in patients exposed to mechanical ventilation.
Scientists have identified a protein called MLKL that plays a crucial role in triggering programmed cell death, known as necroptosis. The discovery could lead to the development of new treatments for chronic inflammatory diseases such as Crohn's disease and rheumatoid arthritis.
Researchers found that apoptosis can reactivate latent herpesviruses in dying cells, which could have significant clinical implications. This discovery highlights the potential for cytotoxic cancer chemotherapies to activate dormant viruses, raising questions about the use of antiviral medications in treatment.
Liping Chen's study found that Shuyusan-containing serum increased survival rates of SH-SY5Y cells, reduced Bax expression, and elevated brain-derived neurotrophic factor mRNA expression. The effect was more pronounced at high doses.
Active prenatal intervention is crucial for optimal outcomes in intrauterine growth-restricted fetuses. Taurine supplement reduces cell apoptosis and promotes neuroprotection through specific signaling pathways.
St. Jude Children's Research Hospital scientists have identified a protein that blocks death of high-risk acute lymphoblastic leukemia cells, leading to a new two-drug combination therapy approach. The study shows promise for treating Ph-positive ALL, a high-risk cancer with limited treatment options.
Researchers at Children's National Hospital discovered that apoptosis activates an 'escape' replication process in human herpesviruses, potentially leading to disease reactivation. This process may be triggered by chemotherapy agents, suggesting the need for antiviral treatment during such procedures.
Researchers uncover how ABL regulatory unit controls cell fate in CML, with implications for cancer treatment. The study finds that anchoring ABL on the cell membrane is essential for apoptosis, highlighting a potential target for novel therapies.
Researchers have discovered that biphasic electrical stimulation can prevent apoptosis in stem cells used to treat spinal cord injuries, offering new hope for patients. The study's findings suggest that BES may be used to improve cell survival and prevent cell death in stem cell-based transplantation therapies.
Transplantation of neural stem cells into tumor-bearing rats inhibits abnormal Ras/Raf/Mek/Erk signaling, promoting apoptosis and potentially treating glioma. This study provides insights into the therapeutic effects of neural stem cell transplantation on glioma in mice.
A new study published in Neural Regeneration Research suggests that X-linked methyl-CpG binding protein 2 (MeCP2) may be a promising therapeutic target for treating Parkinson's disease. Researchers found that overexpressing MeCP2 in damaged human cells reduced apoptosis and increased tyrosine hydroxylase levels, indicating potential be...
A study found cisplatin-induced ototoxicity in mice is mediated by calpain 1 and 2, particularly calpain 2. Calpain's role suggests potential for clinical prevention and treatment strategies to mitigate deafness caused by cisplatin.
New study links aluminum accumulation to neuronal cell death and identifies necrostatin-1 as a substance that counteracts aluminum's neurotoxic effects. In mice treated with aluminum, Nec-1 demonstrated strong protection against cell death and improved cognitive function.
A study published in Nature reveals that the alignment of the mitotic spindle is essential for maintaining epithelial integrity. The researchers found that when the spindle becomes misaligned, it can cause cells to delaminate from the epithelium, leading to tumor-like growths and expression of genes associated with invasive human tumors.
Research found that JNK3 expression is downregulated after traumatic brain injury, which may be associated with apoptosis of nerve cells. This downregulation could promote the recovery of neurological function following traumatic brain injury.
Scientists at St. Jude Children's Research Hospital discovered that protein MCL1 is essential for normal cardiac function, complicating cancer drug development efforts. The study suggests that targeting MCL1 expression in target cells may be beneficial for treating heart muscle damage following heart attacks or other insults.
A team from The Scripps Research Institute has developed a new technique to selectively repress unwanted immune reactions without disabling the immune system as a whole. This method exploits a natural mechanism to target B-cells responsible for Factor VIII rejection, preventing an unwanted immune response in mice for several months.
Scientists discover protein c-FLIP-R that confers protection on immune cells against apoptosis, a type of cellular suicide. The discovery reveals mice with elevated c-FLIP levels are less susceptible to Listeria infections, sparking hope for potential therapeutic approaches.
Researchers discovered neurons employ distinct Caspase mechanisms for axon pruning and apoptosis, providing insights into neurological disorders. The study's findings shed light on the processes underlying neurodevelopmental disorders like schizophrenia and autism.
Researchers at WashU Medicine found a gene called Phr1 that governs the self-destruction of injured axons. Removing this gene can prevent axonal degeneration in adult mice, offering a potential target for new drugs to maintain nerve function.
Researchers at VCU Massey Cancer Center have developed a novel drug combination therapy that targets the PI3K/AKT/mTOR pathway in leukemia cells, leading to profound cell death. The therapy combines ABT-737 and BEZ235, which inhibit pro-survival proteins and reduce apoptosis in cancer cells.
Researchers at the University of Helsinki discovered that the Myc oncoprotein makes cancer cells vulnerable to cell death by activating AMPK, a biochemical sensor. This leads to the activation of tumor suppressor protein p53, which promotes apoptosis in cancer cells.
Researchers found abnormal gene expression in fetuses of obese women, suggesting potential effects on brain development. The study suggests that maternal obesity may contribute to neurodevelopmental abnormalities in children.
A recent study discovered that a lack of proteins Bax and Bak in immune cells can lead to severe autoimmune disease. The research suggests that these proteins play a crucial role in regulating cell death, and their deficiency may be linked to diseases such as type 1 diabetes, rheumatoid arthritis, and lupus.
A new model developed by scientists can predict which patients with colorectal cancer will respond to chemotherapy. The model measures the stress required for a cancer cell to die without harming healthy tissue, and has been shown to robustly predict patient outcomes.
Scientists have engineered Escherichia coli bacteria that can deliberately die to protect their population, promoting the survival of survivors. The altruistic behavior emerges after sufficient time has passed and can be controlled by tuning the extent of programmed cell death.
New research found that lithium-responsive patients exhibit increased expression of anti-apoptotic genes like Bcl2 and IRS2, while those who don't respond show decreased Bcl2 levels. This study provides insight into personalized treatment for bipolar disorder.
Researchers tested APR-246 on 22 patients with advanced blood or prostate cancer, finding indications that the substance restored p53 gene function and triggered cancer cell apoptosis. In two patients, tumor regression was observed, suggesting potential clinical benefits.
Scientists from CNIO describe natural selection at the cellular level, where tissues and organs select the 'best' cells to fend off disease processes. The study reveals the role of haemocytes in eliminating cell residues, shedding light on mechanisms of homeostasis and potential cancer detection.
Researchers identified Puma and Bim as molecules that work together to kill self-reactive immune cells, which accumulate and attack body organs in autoimmune diseases. The study sheds light on the protection mechanism against autoimmune diseases, such as type 1 diabetes and rheumatoid arthritis.
MDC researchers have developed a new treatment approach for acute liver failure by utilizing the protein ARC, which stops excessive apoptosis in the liver. The treatment, TAT-ARC, has been shown to reverse liver failure and restore function in mice, offering a promising new hope for patients with this life-threatening disease.
Researchers have documented the physiological events in lace plant leaves during programmed cell death (PCD), revealing how cells dismantle and disappear. The study used long-term live cell imaging and staining to observe the progression of PCD, which is essential for producing the characteristic holes in the leaves.
Scientists at Scripps Research Institute mapped two essential cellular processes, revealing their cooperation during apoptosis. The study provides insights into programmed cell death and opens a new approach to cancer treatment.
Scientists at Hebrew University and Weizmann Institute discover interaction between proteins responsible for programmed cell death, allowing for potential anti-cancer therapies. The study's findings have the potential to stimulate apoptosis in cancer cells by interfering with protein regulation.
Researchers at IRB Barcelona have identified specific combinations of errors in cell integrity processes as crucial to initiating tumors. The study reveals that genomic instability alone is not sufficient for tumor development and highlights the need for further investigation into cancer's complex origins.
Researchers developed a stapled BIM BH3 peptide that competitively binds to anti-apoptotic proteins, leading to enhanced apoptosis in cancer cells. The compound suppresses tumor growth in mice and works synergistically with other pharmaceutical agents.
Researchers found that viral lytic replication impairs the effectiveness of Nutlin-3, a targeted therapy for KSHV-induced lymphomas. The study suggests reactivating p53 as a selective treatment modality.
A team of researchers has discovered a molecule that prevents cell death when subjected to hyperosmolarity. The TRPM2∆C molecule is activated by binding to CD38 and may lead to new avenues for researching diseases such as HIV, cancer, and diabetes.
Researchers have discovered a novel cell death pathway in bacteria that shares similarities with apoptosis in higher organisms. The newly described Apoptotic-Like Death (ALD) pathway is characterized by DNA fragmentation and depolarization of the cell membrane, similar to eukaryotic apoptosis.
Researchers discovered that mitochondrial DNA mutations cause programmed cell death in the inner ear, leading to inherited deafness. The study found that reactive oxygen molecules produced by diseased mitochondria trigger a cell death-inducing gene expression program.
A new study has discovered a way to prevent septic shock by blocking a specific form of cell death called necroptosis. The approach fully protects mice against the fatal inflammation, offering a potential new target for therapy. Researchers found that eliminating RIPK molecules led to full protection against sepsis.
Researchers discovered a gene that protects against colorectal cancer by causing cell death, but this mechanism is often blocked in human cancers. The gene, DCC, codes for a 'dependence receptor' that induces apoptosis when it's depleted of ligands.
Researchers discovered a long non-coding RNA (lncRNA) that prevents programmed cell death in maturing red blood cells, a process linked to leukemias and cancers. This lncRNA may represent a new avenue of attack for therapeutics.